TY - GEN
T1 - LC-MS analysis of markers for advanced glycation endproducts -protein/peptides adducts
AU - Ahmad, Waqar
AU - Li, Bo
AU - Parveen, Zahida
AU - Saeed, Muhammad Khalid
AU - Xiao, Shengyuan
AU - Deng, Yulin
PY - 2007
Y1 - 2007
N2 - Advanced glycation end products (AGEs) are a heterogeneous group of proteins that have been modified with glucose or carbohydrates adducts, and are thought to be responsible for many complications of diabetes and aging. Free amino groups of proteins react slowly with reducing sugars such as glucose by the glycation or Maillard reaction, initially forming Schiff bases, which undergo rearrangement to form the relatively stable Amadori products. The Amadori products subsequently degrade into a-dicarbonyl compounds that react with amino groups of proteins to form cross-links, stable end products called Advanced Glycation End Products (AGEs). AGEs have been shown to react (cross-link) with the amino group of the N-terminal amino acid residue and the side-chains of arginine and lysine residues. Therefore, glucose has been shown to be responsible, at least in part, for protein cross-linkage, oxidative stress and cytotoxicity. In this in vitro study model, the crosslinking of Glucose (0.05, 0.5, 1.0 and 2.5 M) with Bovine Serum Albumin incubated for different intervals of time (0, 7, 14, 21, 28 and 35 days) was studied using LC-MS and Mascot database to search for the possible markers for glucose-peptides adducts. A total of twenty-seven peptides were matched in the database search query for control BSA out of which seven (m/z 922.69, 464.36, 582.41, 681.95, 834.49, 847.59 and 812.87) were found to be the possible markers for AGEs-protein/peptides adducts.
AB - Advanced glycation end products (AGEs) are a heterogeneous group of proteins that have been modified with glucose or carbohydrates adducts, and are thought to be responsible for many complications of diabetes and aging. Free amino groups of proteins react slowly with reducing sugars such as glucose by the glycation or Maillard reaction, initially forming Schiff bases, which undergo rearrangement to form the relatively stable Amadori products. The Amadori products subsequently degrade into a-dicarbonyl compounds that react with amino groups of proteins to form cross-links, stable end products called Advanced Glycation End Products (AGEs). AGEs have been shown to react (cross-link) with the amino group of the N-terminal amino acid residue and the side-chains of arginine and lysine residues. Therefore, glucose has been shown to be responsible, at least in part, for protein cross-linkage, oxidative stress and cytotoxicity. In this in vitro study model, the crosslinking of Glucose (0.05, 0.5, 1.0 and 2.5 M) with Bovine Serum Albumin incubated for different intervals of time (0, 7, 14, 21, 28 and 35 days) was studied using LC-MS and Mascot database to search for the possible markers for glucose-peptides adducts. A total of twenty-seven peptides were matched in the database search query for control BSA out of which seven (m/z 922.69, 464.36, 582.41, 681.95, 834.49, 847.59 and 812.87) were found to be the possible markers for AGEs-protein/peptides adducts.
KW - Bovine serum albumin (BSA)
KW - Glucose
KW - LC-MS: Advanced glycation endproducts (AGEs)
KW - Markers
KW - Peptides
UR - http://www.scopus.com/inward/record.url?scp=48149090178&partnerID=8YFLogxK
U2 - 10.1109/ICCME.2007.4382043
DO - 10.1109/ICCME.2007.4382043
M3 - Conference contribution
AN - SCOPUS:48149090178
SN - 1424410789
SN - 9781424410781
T3 - 2007 IEEE/ICME International Conference on Complex Medical Engineering, CME 2007
SP - 1726
EP - 1733
BT - 2007 IEEE/ICME International Conference on Complex Medical Engineering, CME 2007
T2 - 2007 IEEE/ICME International Conference on Complex Medical Engineering, CME 2007
Y2 - 23 May 2007 through 27 May 2007
ER -